Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 12:45 AM
NCT ID:
NCT00372060
Pre Assignment Details:
Following a screening period of at least 4 weeks and a 2 or 8-week observation period, patients who were on pioglitazone monotherapy for at least 8 weeks and met all other entry criteria were randomized to receive: sitagliptin/sitagliptin or placebo/sitagliptin.
The starting dose of sitagliptin was 50 mg for all patients.
Recruitment Details:
Phase III.
Date of first patient in: 22 August 2006. Date of last patient's last visit for Period I: 1 May 2007.
Date of last patient's last visit for Period II: 5 February 2008. Number of randomized patients: 134.
The study was conducted at 32 centers in Japan.
Study:
NCT00372060
Study Brief:
Results Section:
NCT00372060